FDA clears OTC cuffless BP monitor | Cardiologist killed | New heart pump implanted for first time | Medicare covers TriClip

The cuffless technology, which has already gained CE mark approval, should make its U.S. debut in 2026.

A prominent doctor and multiple family members are dead after an Israeli airstrike. "Thousands of heart patients will suffer as a result of his killing," one colleague said.

The FDA's 2024 approval of the Farapulse system covered patients with paroxysmal atrial fibrillation. Now, however, the technology is officially approved for patients with more persistent symptoms. 

The CorWave technology is unlike other left ventricular assist devices, working in harmony with the patient's heartbeat and making adjustments as needed. 

CMS has finalized a new national coverage determination for T-TEER, sometimes known as transcatheter tricuspid valve repair. Abbott's TriClip is the only device approved by the FDA for T-TEER, but other treatment options are under development.

Cardiology continues to be one of the most influential healthcare specialties when it comes to utilizing artificial intelligence. 

The new drug, LX2006, has already received the FDA's fast track designation. This latest distinction was based on early data from two separate clinical trials.

The Siegel TAVR valve includes no nickel or cobalt. In fact, its frame was built using special alloys specifically developed by MiRus. 

Researchers hope these policies can be standardized in the future to help avoid confusion and improve clinician safety.

When doctors are accused of mishandling the heart health of a young athlete, it occasionally ends up being settled in a courtroom.